CardiologyClinical trial for patients suffering from hypertension, stable coronary disease and stable chronic cardiac insufficiency
Non-interventional trial with partially retrospective and prospective evaluation of clinical effectiveness of Ramipril in monotherapy or Bisoprolol in a routine combined therapy in relation to combined administration of Ramipril with Bisoprolol as single components in doses commonly used in everyday practice in patients suffering from hypertension, stable coronary disease and stable chronic cardiac insufficiency
This is a non-interventional, observational trial. It is aimed at evaluation of effectiveness and safety of use of a given drug in routine therapy in patients with hypertension, intensive coronary disease or stable chronic cardiac insufficiency.
Who can participate?
All patients suffering from hypertension, coronary disease, chronic cardiac insufficiency and newly diagnosed patients, aged 18 to 85.
What will patients receive as part of their participation in a trial?
Free-of charge medical care and cardiological treatment in a period of three months of the duration of trial.
Recruitment completion: February 2020.